MYH9 and nasopharyngeal carcinoma: In this study, we observed that MYH9 not only interacted with GSK3β but also increased the ubiquitination and degradation of GSK3β protein via the activity of the E3 ubiquitin-linked enzyme TRAF6, which then upregulated β-catenin expression and induced its nuclear translocation in NPC cells.